134 related articles for article (PubMed ID: 9368481)
21. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
[TBL] [Abstract][Full Text] [Related]
22. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
23. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
24. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
25. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
Rodeghiero F; Castaman G; Dini E
Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
[TBL] [Abstract][Full Text] [Related]
26. L-asparaginase in acute lymphoblastic leukemia treatment: the role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy.
Pogliani EM; Parma M; Baragetti I; Mostarda G; Rivolta F; Maffé P; Corneo G
Acta Haematol; 1995; 93(1):5-8. PubMed ID: 7725851
[TBL] [Abstract][Full Text] [Related]
27. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
28. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
[TBL] [Abstract][Full Text] [Related]
29. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
[TBL] [Abstract][Full Text] [Related]
30. Ocular complications of sigmoid sinus thrombosis from L-asparaginase.
Foroozan R
J Pediatr Ophthalmol Strabismus; 2005; 42(2):117-9. PubMed ID: 15825749
[TBL] [Abstract][Full Text] [Related]
31. Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors.
Wermes C; Fleischhack G; Junker R; Schobess R; Schwabe D; Sykora KW; Nowak-Göttl U
Klin Padiatr; 1999; 211(4):211-4. PubMed ID: 10472552
[TBL] [Abstract][Full Text] [Related]
32. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.
Ghanem KM; Dhayni RM; Al-Aridi C; Tarek N; Tamim H; Chan AKC; Saab R; Abboud MR; El-Solh H; Muwakkit SA
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660695
[TBL] [Abstract][Full Text] [Related]
33. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia.
Millan NC; Pastrana A; Guitter MR; Zubizarreta PA; Monges MS; Felice MS
Leuk Res; 2018 Feb; 65():86-93. PubMed ID: 29328996
[TBL] [Abstract][Full Text] [Related]
34. Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapy.
Higuchi T; Mori H; Niikura H; Omine M; Okada S; Terada H
Ann Hematol; 1998 Jun; 76(6):263-9. PubMed ID: 9692814
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
Larson RA; Fretzin MH; Dodge RK; Schiffer CA
Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
[TBL] [Abstract][Full Text] [Related]
36. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.
Liang DC; Hung IJ; Yang CP; Lin KH; Chen JS; Hsiao TC; Chang TT; Pui CH; Lee CH; Lin KS
Leukemia; 1999 Feb; 13(2):155-60. PubMed ID: 10025887
[TBL] [Abstract][Full Text] [Related]
37. Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.
Zuurbier SM; Lauw MN; Coutinho JM; Majoie CB; van der Holt B; Cornelissen JJ; Middeldorp S; Biemond BJ; Stam J
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1679-84. PubMed ID: 25934140
[TBL] [Abstract][Full Text] [Related]
38. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
[TBL] [Abstract][Full Text] [Related]
39. Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy.
Imamura T; Morimoto A; Kato R; Izumi M; Murakami A; Matuo S; Kiyosawa N; Kano G; Yoshioka H; Sugimoto T; Imashuku S
Leuk Lymphoma; 2005 May; 46(5):729-35. PubMed ID: 16019511
[TBL] [Abstract][Full Text] [Related]
40. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]